Search research articles
Contact Us
Filters
Showing results (91-100 of 213) with videos related to
Page
of 22
Sort By:
Lancet (London, England)
|
February 6, 1988
Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction
N Sharpe, J Murphy, H Smith, et al.
Journal of Food Protection
|
March 17, 2019
Effect of Pre-Filtration and Enzyme Treatment on Membrane Filtration of Foods
Phyllis Entis, Michael H Brodsky, Anthony N Sharpe
The New Zealand Medical Journal
|
June 28, 1995
Thrombolysis in acute myocardial infarction: reducing in hospital treatment delay
G Porter, R Doughty, G Gamble, et al.
The New Zealand Medical Journal
|
June 11, 1980
Captopril in the treatment of refractory high-renin hypertension
R Cutfield, D N Sharpe, E D Clarke
Laboratory Practice
|
December 1, 1975
Self-cleaning bacteriological pipette using ultrasonic vibration
A N Sharpe, G L Michaud, J Pérusse
Applied and Environmental Microbiology
|
January 1, 1979
Membrane filtration of food suspensions
A N Sharpe, P I Peterkin, I Dudas
British Heart Journal
|
May 1, 1975
Treatment with digoxin and measurement of serum digoxin levels after myocardial infarction
D N Sharpe, R M Norris, B McL White
The Journal of Applied Bacteriology
|
December 1, 1970
Adenosinetriphosphate (ATP) levels in foods contaminated by bacteria
A N Sharpe, M N Woodrow, A K Jackson
International Journal of Clinical Pharmacology and Therapeutics
|
May 31, 2001
Does intention-to-treat analysis answer all questions in long-term mortality trials? Considerations on the basis of the ANZ trial
H C Tillmann, N Sharpe, G Sponer, et al.
Canadian Journal of Microbiology
|
February 1, 1985
Effect of homogenization procedures on Escherichia coli counts in naturally contaminated cheese
P I Peterkin, A N Sharpe, D W Warburton
Page
of 22
Search research articles
Search
Showing results (91-100 of 213) with videos related to
Sort By:
Page
of 22
Lancet (London, England)
|
February 6, 1988
Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction
N Sharpe, J Murphy, H Smith, et al.
Journal of Food Protection
|
March 17, 2019
Effect of Pre-Filtration and Enzyme Treatment on Membrane Filtration of Foods
Phyllis Entis, Michael H Brodsky, Anthony N Sharpe
The New Zealand Medical Journal
|
June 28, 1995
Thrombolysis in acute myocardial infarction: reducing in hospital treatment delay
G Porter, R Doughty, G Gamble, et al.
The New Zealand Medical Journal
|
June 11, 1980
Captopril in the treatment of refractory high-renin hypertension
R Cutfield, D N Sharpe, E D Clarke
Laboratory Practice
|
December 1, 1975
Self-cleaning bacteriological pipette using ultrasonic vibration
A N Sharpe, G L Michaud, J Pérusse
Applied and Environmental Microbiology
|
January 1, 1979
Membrane filtration of food suspensions
A N Sharpe, P I Peterkin, I Dudas
British Heart Journal
|
May 1, 1975
Treatment with digoxin and measurement of serum digoxin levels after myocardial infarction
D N Sharpe, R M Norris, B McL White
The Journal of Applied Bacteriology
|
December 1, 1970
Adenosinetriphosphate (ATP) levels in foods contaminated by bacteria
A N Sharpe, M N Woodrow, A K Jackson
International Journal of Clinical Pharmacology and Therapeutics
|
May 31, 2001
Does intention-to-treat analysis answer all questions in long-term mortality trials? Considerations on the basis of the ANZ trial
H C Tillmann, N Sharpe, G Sponer, et al.
Canadian Journal of Microbiology
|
February 1, 1985
Effect of homogenization procedures on Escherichia coli counts in naturally contaminated cheese
P I Peterkin, A N Sharpe, D W Warburton
Page
of 22